Biotech Bill Has Loophole That Could Undermine Its Purpose
Executives argue that a proposed law aimed at shielding U.S. biotech from Chinese rivals contains a significant gap. The loophole could allow companies to circumvent the restrictions through certain geographic arrangements. They urge industry leaders to address this before stricter legislation is enacted.
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Opinion: STAT+: A bill is supposed to protect U.S. biotech from Chinese competition. But there’s a loophole.” Browse more stories.